Dec 6, 2024
Virginia Foxx- Amount
- $15,001 to $50,000
- Filed
- Jan 6, 2025
Congress ticker disclosure profile
As of August 1 at 11:21 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference ASC. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
11
Member filers
1
Disclosed ranges
$113K
Most active member desks
10 buys vs 1 sells
Latest trade Dec 6, 2024
Dec 6, 2024
Virginia FoxxJul 11, 2024
Virginia FoxxJul 9, 2024
Virginia FoxxJul 8, 2024
Virginia FoxxApr 9, 2024
Virginia FoxxMar 6, 2024
Virginia FoxxMar 4, 2024
Virginia FoxxFeb 27, 2024
Virginia FoxxFeb 23, 2024
Virginia FoxxFeb 15, 2024
Virginia FoxxFeb 5, 2024
Virginia Foxx| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Dec 6, 2024 | Virginia Foxx | Sell | $15,001 to $50,000 | Jan 6, 2025 | Open card |
| Jul 11, 2024 | Virginia Foxx | Buy | $1,001 to $15,000 | Aug 6, 2024 | Open card |
| Jul 9, 2024 | Virginia Foxx | Buy | $1,001 to $15,000 | Aug 6, 2024 | Open card |
| Jul 8, 2024 | Virginia Foxx | Buy | $1,001 to $15,000 | Aug 6, 2024 | Open card |
| Apr 9, 2024 | Virginia Foxx | Buy | $1,001 to $15,000 | May 6, 2024 | Open card |
| Mar 6, 2024 | Virginia Foxx | Buy | $1,001 to $15,000 | Apr 10, 2024 | Open card |
| Mar 4, 2024 | Virginia Foxx | Buy | $1,001 to $15,000 | Apr 10, 2024 | Open card |
| Feb 27, 2024 | Virginia Foxx | Buy | $1,001 to $15,000 | Mar 7, 2024 | Open card |
| Feb 23, 2024 | Virginia Foxx | Buy | $1,001 to $15,000 | Mar 7, 2024 | Open card |
| Feb 15, 2024 | Virginia Foxx | Buy | $1,001 to $15,000 | Mar 7, 2024 | Open card |
| Feb 5, 2024 | Virginia Foxx | Buy | $1,001 to $15,000 | Mar 7, 2024 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 11 of 11 filed rows include disclosed amount ranges (100%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.